No Data
No Data
ST Bering: Corrections to the 2023 Annual Report
Investors in Guizhou Bailing Group Pharmaceutical (SZSE:002424) From Five Years Ago Are Still Down 64%, Even After 9.8% Gain This Past Week
ST BALLING: 2024 Semi-Annual Report
ST Bering: 2024 Semi-Annual Report Summary
Both Individual Investors Who Control a Good Portion of Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Along With Institutions Must Be Dismayed After Last Week's 7.7% Decrease
Special treat Bai Ling (002424.SZ): has initiated the application procedure for the new drug IND of Tangning Tongluo.
On August 16th, Gelonhui reported that Special Treat Baoling (002424.SZ) has initiated the application process for IND of Tongning New Drug. After obtaining phased progress, the company will fulfill its disclosure obligations in a timely manner.
No Data
No Data